Accession | ARO:3007839 |
Definition | CIM (C. indologenes MBL) are a family of subclass B1 metallo-beta-lactamases originally identified from Chryseobacterium indologenes, and which exhibit carbapenem-hydrolyzing activity. |
Drug Class | carbapenem, cephalosporin |
Resistance Mechanism | antibiotic inactivation |
Classification | 12 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + determinant of antibiotic resistance + antibiotic inactivation [Resistance Mechanism] + antibiotic inactivation enzyme + hydrolysis of antibiotic conferring resistance + antibiotic molecule + hydrolysis of beta-lactam antibiotic by metallo-beta-lactamase + beta-lactam antibiotic + beta-lactamase + cephem + class B (metallo-) beta-lactamase |
Parent Term(s) | 3 ontology terms | Show + confers_resistance_to_drug_class carbapenem [Drug Class] + confers_resistance_to_drug_class cephalosporin [Drug Class] + subclass B1 (metallo-) beta-lactamase |
Sub-Term(s) | 1 ontology terms | Show + CIM-1 |
Publications | Wang Y, et al. 2024. Commun Biol 7(1):282 Identification and characterization of CIM-1, a carbapenemase that adds to the family of resistance factors against last resort antibiotics. (PMID 38454015) |